Sutro Biopharma
STRO
$3.81
Share price
1.87%
Change (1 day)
-16.81%
Change (1 year)
Categories
Operating Margin for Sutro Biopharma (STRO)
Operating Margin as of May 2024 (TTM): -167.26%
According to Sutro Biopharma's latest financial reports and stock price the company's current Operating Margin is -167.26%. At the end of 2021 the company had an Operating Margin of -170.55%.
Operating Margin history for Sutro Biopharma from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -170.55% | 126.79% |
| 2020 | -75.20% | -42.35% |
| 2019 | -130.44% | 41.89% |
| 2018 | -91.93% | 141.59% |
| 2017 | -38.05% | -1435.39% |
| 2016 | 2.85% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -78.26% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 4,916.83% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.